Glenn Foundation for Medical Research Discovery Award
Forecasted
The Glenn Foundation for Medical Research Discovery Award funds innovative research into the biological mechanisms of aging to advance understanding and improve human healthspan.
Funder: American Federation for Aging Research
Due Dates (Anticipated): February 2027 (Letter of Intent) | July 2027 (Full application)
Funding Amounts: Up to two awards; $555,000 each over three years ($185,000/year; max 8% indirect costs)
Summary: Supports innovative research into the biological mechanisms of human aging, aiming to advance discoveries that improve healthspan.
Key Information: Projected dates; program seeks new directions in aging biology, not incremental work.
Description
The Glenn Foundation for Medical Research Discovery Award, administered in partnership with the American Federation for Aging Research (AFAR), is designed to support groundbreaking research that uncovers the biological mechanisms underlying normal human aging and its related physiological decline. The program especially encourages applications from investigators whose expertise lies outside traditional aging research but whose work is relevant to the biology of aging. The focus is on bold, innovative projects that could yield new discoveries or establish novel approaches relevant to extending human healthspan. Projects that narrowly focus on aging as a disease or on specific diseases (unless directly tied to aging biology) are discouraged. Awardees are expected to participate in collaborative scientific meetings organized by AFAR and the Glenn Foundation.
